Valley National Advisers »

Cytek Biosciences shares owned by Valley National Advisers

Quarter-by-quarter ownership of Cytek Biosciences (CTKB) shares owned by Valley National Advisers from 13F filings

Historical chart of Valley National Advisers investment in Cytek Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cytek Biosciences held by Valley National Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytek Biosciences by Valley National Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $999 120 8.33

More positions owned by Valley National Advisers

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Apple (AAPL)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Value Etf (VTV)
Pimco Etf Tr Active Bd Etf (BOND)
Ishares Tr Core Total Usd (IUSB)
Lam Research Corporation (LRCX)
Schwab Strategic Tr Us Mid-cap Etf (SCHM)
Comcast Corp Cl A (CMCSA)
Lockheed Martin Corporation (LMT)
Amazon (AMZN)

View all positions for Valley National Advisers

Top funds holding Cytek Biosciences

Vanguard Group
RA Capital Management
Hillhouse Capital Advisors
New York State Common Retirement Fund
Wellington Management Company
Dimensional Fund Advisors
Charles Schwab Investment Management
Bank of New York Mellon
Goldman Sachs Group
Connor, Clark & Lunn Investment Management
Principal Financial Group
Rhumbline Advisers
Legal & General Group
State of Wisconsin Investment Board
Swiss National Bank

View all funds holding Cytek Biosciences